CD209 and nonpapillary renal cell carcinoma: According to their presence in Tertiary lymphoid structures (TLS), DCs in ccRCC can be divided into two subtypes: TLS-DCs (CD83+ DC- LAMP+), which are very uncommon in ccRCC and associated with good outcomes, and non-TLS-DCs (CD209+ CD83), which are dominant in ccRCC TIME and associated with the worst prognosis.